April 22, 2024

Webinar – Singleron AccuraCode®: Cost-effective, High-Throughput mRNA sequencing for Drug Discovery

Webinar – Singleron AccuraCode®: Cost-effective, High-Throughput mRNA sequencing for Drug Discovery

Join our exclusive webinar to explore how AccuraCode® can streamline your bulk mRNA sequencing workflow and reduce costs. This solution is suited for pharma and biotech R&D teams seeking to improve compound screening efficiency, study mechanism of action, or identify biomarkers.

This session will delve into:
– How our AccuraCode® Kit combines accurate barcoding technology with bulk mRNA-seq to generate sequencing libraries of hundreds of samples in one single tube.
– How AccuraCode® TCR enables efficient, accurate, and scalable exploration of T-cell repertoires of multiple samples—revealing clonotypes, V(D)J recombination patterns, and diversity.
– How our solutions can accelerate your high-throughput screening to expand the drug discovery horizons

Engage with our speakers during a live Q&A session at the end of the webinar to have all your questions answered.
Register now to secure your spot and take the first step towards faster insights!

You are currently viewing a placeholder content from Default. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

register now

Our latest News

discover more
Helping children with cancer with flowers

Helping children with cancer with flowers

From April 28 to May 24, you can once again buy and give flower creations throughout Germany for the benefit of children and young people with cancer. With its campaign “Blumen schenken. Hoffnung spenden.” (Give flowers. Spread hope.) the Hopp Children’s Cancer Center Heidelberg (KiTZ) wants to draw attention to the urgently needed research for […]

Blenrep (belantamab mafodotin) combinations approved by UK MHRA in relapsed/refractory multiple myeloma

Blenrep (belantamab mafodotin) combinations approved by UK MHRA in relapsed/refractory multiple myeloma

GSK plc (LSE/NYSE: GSK) today announced the authorisation of Blenrep by the Medicines and Healthcare products Regulatory Agency (MHRA). In the UK, Blenrep is approved for the treatment of adults with multiple myeloma in combination with bortezomib plus dexamethasone (BVd) in patients who have received at least one prior therapy, and in combination with pomalidomide plus dexamethasone (BPd) in […]

New regulatory protein of the neuronal cytoskeleton identified

New regulatory protein of the neuronal cytoskeleton identified

The growth and function of nerve cells is based on a lattice-like structure called membrane-associated periodic skeleton (MPS). However, how the organization of the MPS is controlled has not been elucidated until now. A team from the Max Planck Institutes for Medical Research and for Multidisciplinary Sciences has now discovered that it is regulated by […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp